07 August 2025 : Database Analysis
Trends and Efficacy in Clostridioides difficile Infection Management at a Polish Clinical Hospital
Jarosław Drobnik
ABDEG 1, Piotr Pobrotyn ADEFG 2*, Urszula Grata-Borkowska DF 1, Katarzyna Madziarska DE 3, Mateusz Baran ABCDEF 4
DOI: 10.12659/MSM.948254
Med Sci Monit 2025; 31:e948254
Table 6 Analysis of the treatment of CDI depending on the sex of patients hospitalized at the UCHW in 2016–2018.
| Method of treatment (%) | Male | Female | P |
|---|---|---|---|
| Metronidazole only | 40 (30.1) | 46 (26.6) | 0.596 |
| Vancomycin only | 29 (21.8) | 35 (20.2) | |
| Metronidazole and vancomycin | 55 (414) | 73 (42.2) | |
| Rifaximin or fidaxomicin and metronidazole and/or vancomycin | 9 (6.8) | 19 (11.0) |